Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Exagen Inc shares valued at $1,155,000 were sold by NMSIC Co-Investment Fund, L.P. on Mar 25 ’25. At $3.30 per share, NMSIC Co-Investment Fund, L.P. sold 350,000 shares. The insider’s holdings dropped to 1,758,958 shares worth approximately $12.4 million following the completion of this transaction.
Also, NMSIC Co-Investment Fund, L.P. sold 200,000 shares, netting a total of over 660,040 in proceeds. Following the sale of shares at $3.30 each, the insider now holds 2,108,958 shares.
Before that, Black Jeffrey G. had added 22,298 shares to its account. In a trade valued at $66,448, the Chief Financial Officer bought Exagen Inc shares for $2.98 each. Upon closing the transaction, the insider’s holdings increased to 22,298 shares, worth approximately $1.94 million.
As published in a research note from KeyBanc Capital Markets on August 05, 2022, Exagen Inc [XGN] has been rated down from an Overweight to a Sector weight. As of April 15, 2021, Canaccord Genuity has initiated its “Buy” rating for XGN. Earlier on November 10, 2020, KeyBanc Capital Markets initiated its rating. Their recommendation was “an Overweight” for XGN stock.
Analyzing XGN Stock Performance
On last trading session, Exagen Inc [NASDAQ: XGN] rose 1.15% to $7.05. The stock’s lowest price that day was $6.92, but it reached a high of $7.1 in the same session. During the last five days, there has been a surge of approximately 0.86%. Over the course of the year, Exagen Inc shares have jumped approximately 289.50%. Shares of the company reached a 52-week high of $7.95 on 06/18/25 and a 52-week low of $2.67 on 03/04/25.
Support And Resistance Levels for Exagen Inc (XGN)
According to the 24-hour chart, there is a support level at 6.95, which, if violated, would cause prices to drop to 6.84. In the upper region, resistance lies at 7.13. The next price resistance is at 7.20. RSI (Relative Strength Index) is 53.32 on the 14-day chart, showing neutral technical sentiment.
Is Exagen Inc subject to short interest?
Stocks of Exagen Inc saw a sharp rise in short interest on 2025-06-13 jumping by 60614.0 shares to 0.2 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 0.14 million shares. A jump of 29.59% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.92 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.92.
Which companies own the most shares of Exagen Inc (XGN)?
In terms of Exagen Inc share price expectations, FactSet research, analysts set an average price target of 5 in the next 12 months, down nearly -28.26% from the previous closing price of $6.97. Analysts anticipate Exagen Inc stock to reach 5 by 2025, with the lowest price target being 5. In spite of this, 2 analysts ranked Exagen Inc stock as Buy at the end of 2025. On October 08, 2020, BTIG Research assigned a price target of “a Buy” to the stock and initiated coverage with a $18.
